171 related articles for article (PubMed ID: 20625867)
1. Phenotypic high-throughput screening in atherosclerosis research: focus on macrophages.
Muslin AJ
J Cardiovasc Transl Res; 2010 Oct; 3(5):448-53. PubMed ID: 20625867
[TBL] [Abstract][Full Text] [Related]
2. Fluid-phase pinocytosis of LDL by macrophages: a novel target to reduce macrophage cholesterol accumulation in atherosclerotic lesions.
Kruth HS
Curr Pharm Des; 2013; 19(33):5865-72. PubMed ID: 23438954
[TBL] [Abstract][Full Text] [Related]
3. IL-33 reduces macrophage foam cell formation.
McLaren JE; Michael DR; Salter RC; Ashlin TG; Calder CJ; Miller AM; Liew FY; Ramji DP
J Immunol; 2010 Jul; 185(2):1222-9. PubMed ID: 20543107
[TBL] [Abstract][Full Text] [Related]
4. LDL inhibits the mediation of cholesterol efflux from macrophage foam cells by apoA-I-containing lipoproteins. A putative mechanism for foam cell formation.
Nakamura R; Ohta T; Ikeda Y; Matsuda I
Arterioscler Thromb; 1993 Sep; 13(9):1307-16. PubMed ID: 8364015
[TBL] [Abstract][Full Text] [Related]
5. Sage weed (Salvia plebeia) extract antagonizes foam cell formation and promotes cholesterol efflux in murine macrophages.
Park SH; Kim JL; Kang MK; Gong JH; Han SY; Shim JH; Lim SS; Kang YH
Int J Mol Med; 2012 Nov; 30(5):1105-12. PubMed ID: 22922992
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of Dioscin on atherosclerosis and foam cell formation in hyperlipidemia rats.
Wang P; He LY; Shen GD; Li RL; Yang JL
Inflammopharmacology; 2017 Dec; 25(6):633-642. PubMed ID: 28365854
[TBL] [Abstract][Full Text] [Related]
7. Foam cell formation: A new target for fighting atherosclerosis and cardiovascular disease.
Maguire EM; Pearce SWA; Xiao Q
Vascul Pharmacol; 2019 Jan; 112():54-71. PubMed ID: 30115528
[TBL] [Abstract][Full Text] [Related]
8. Transient Receptor Potential Ankyrin 1 Channel Involved in Atherosclerosis and Macrophage-Foam Cell Formation.
Zhao JF; Shyue SK; Kou YR; Lu TM; Lee TS
Int J Biol Sci; 2016; 12(7):812-23. PubMed ID: 27313495
[TBL] [Abstract][Full Text] [Related]
9. Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosis.
Patel KM; Strong A; Tohyama J; Jin X; Morales CR; Billheimer J; Millar J; Kruth H; Rader DJ
Circ Res; 2015 Feb; 116(5):789-96. PubMed ID: 25593281
[TBL] [Abstract][Full Text] [Related]
10. Metformin ameliorates Ox-LDL-induced foam cell formation in raw264.7 cells by promoting ABCG-1 mediated cholesterol efflux.
He X; Chen X; Wang L; Wang W; Liang Q; Yi L; Wang Y; Gao Q
Life Sci; 2019 Jan; 216():67-74. PubMed ID: 30218721
[TBL] [Abstract][Full Text] [Related]
11. The detrimental effect of asymmetric dimethylarginine on cholesterol efflux of macrophage foam cells: Role of the NOX/ROS signaling.
Chen CH; Zhao JF; Hsu CP; Kou YR; Lu TM; Lee TS
Free Radic Biol Med; 2019 Nov; 143():354-365. PubMed ID: 31437479
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol Derivative, Trans-3, 5, 4'-Trimethoxystilbene, Prevents the Developing of Atherosclerotic Lesions and Attenuates Cholesterol Accumulation in Macrophage Foam Cells.
Hong M; Li J; Li S; Almutairi MM
Mol Nutr Food Res; 2020 Mar; 64(6):e1901115. PubMed ID: 31965713
[TBL] [Abstract][Full Text] [Related]
13. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
14. Shuttle/sink model composed of β-cyclodextrin and simvastatin-loaded discoidal reconstituted high-density lipoprotein for enhanced cholesterol efflux and drug uptake in macrophage/foam cells.
He J; Yang Y; Zhou X; Zhang W; Liu J
J Mater Chem B; 2020 Feb; 8(7):1496-1506. PubMed ID: 31999290
[TBL] [Abstract][Full Text] [Related]
15. Foam cells in atherosclerosis.
Yu XH; Fu YC; Zhang DW; Yin K; Tang CK
Clin Chim Acta; 2013 Sep; 424():245-52. PubMed ID: 23782937
[TBL] [Abstract][Full Text] [Related]
16. Ramipril administration to atherosclerotic mice reduces oxidized low-density lipoprotein uptake by their macrophages and blocks the progression of atherosclerosis.
Hayek T; Kaplan M; Raz A; Keidar S; Coleman R; Aviram M
Atherosclerosis; 2002 Mar; 161(1):65-74. PubMed ID: 11882318
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrion-Targeted Peptide SS-31 Inhibited Oxidized Low-Density Lipoproteins-Induced Foam Cell Formation through both ROS Scavenging and Inhibition of Cholesterol Influx in RAW264.7 Cells.
Hao S; Ji J; Zhao H; Shang L; Wu J; Li H; Qiao T; Li K
Molecules; 2015 Dec; 20(12):21287-97. PubMed ID: 26633327
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein degradation and cholesterol esterification in primary cell cultures of rabbit atherosclerotic lesions.
Jaakkola O; Nikkari T
Am J Pathol; 1990 Aug; 137(2):457-65. PubMed ID: 2201201
[TBL] [Abstract][Full Text] [Related]
19. 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus.
Oh J; Weng S; Felton SK; Bhandare S; Riek A; Butler B; Proctor BM; Petty M; Chen Z; Schechtman KB; Bernal-Mizrachi L; Bernal-Mizrachi C
Circulation; 2009 Aug; 120(8):687-98. PubMed ID: 19667238
[TBL] [Abstract][Full Text] [Related]
20. Sortilin promotes macrophage cholesterol accumulation and aortic atherosclerosis through lysosomal degradation of ATP-binding cassette transporter A1 protein.
Lv Y; Yang J; Gao A; Sun S; Zheng X; Chen X; Wan W; Tang C; Xie W; Li S; Guo D; Peng T; Zhao G; Zhong L
Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):471-483. PubMed ID: 30950489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
